新辅助治疗在食管胃结合部腺癌中的研究进展

Research progress of neoadjuvant therapy in adenocarcinoma of the esophagogastric junction

食管胃结合部腺癌单纯手术治疗效果并不理想,预后较差,目前尚缺乏专门针对食管胃结合部腺癌的标准治疗方案.新辅助治疗包括新辅助放疗、化疗及新辅助放化疗,它们在食管胃结合部腺癌治疗中的应用及疗效仍存在争议.

Surgery alone for the adenocarcinoma of the esophagogastric junction （AEG） often gives unsatisfactory results, with a poor prognosis.At present, there is no unified therapeutic regimen specifically for AEG.Neoadjuvant therapy includes neoadjuvant radiotherapy, chemotherapy and chemoradiotherapy, but the applications and effects of them for AEG are still controversial.